参考文献/References:
[1] 丁芳,王峰磊,杨波,等.高血压患者血清脂肪酸与血压的相关性研究[J].浙江预防医学,2015,6:551-555.
[2] Nyantika AN,Tupmainen TP,Kauhanen J,et al.Serum long-chain n-3 polyunsaturated fatty acids, methylmercury and blood pressure in an older population[J].J Nutr Health Aging,2015,19(5):498-503.
[3] Huang T,Shou T,Cai N,et al.Associations of plasma n-3 polyunsaturated fatty acids with blood pressure and cardiovascular risk factors among Chinese[J].Int J Food Sci Nutr,2012,63(6):667-673.
[4] Liu JC,Conklin SM, Manuck SB,et al.Long-chain omega-3 fatty acids and blood pressure[J].Am J Hypertens,2011,24(10):1121-1126.
[5] Shantakumari N,Eldeeb RA,Ibrahim SA,et al.Effect of PUFA on patients with hypertension:a hospital based study[J].Indian Heart J,2014,66(4):408-414.
[6] Hoshi T,Wissuwa B,Tian Y,et al.Omega-3 fatty acids lower blood pressure by directly activating large-conductance Ca2+-dependent K+ channels [J]. Proc Natl Acad Sci U S A,2013,110(12):4816-4821.
[7] 倪珺,陆利民.肾脏血管紧张素转化酶2 [J].生理科学进展,2012,2:145-149.
[8] Wang RX,Chai Q, Lu T,et al.Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity[J].Cardiovasc Res,2011,90(2):344-352.
[9] 刘立新.Omega-3脂肪酸对高血压合并颈动脉粥样硬化患者血管内皮功能的影响[J].中国临床药理学杂志,2010,5:330-333.
[10] Urabe Y,Yamamoto H,Kitagawa T,et al. Association between serum levels of n-3 polyunsaturated fatty acids and coronary plaque detected by coronary computed tomography angiography in patients receiving statin therapy[J].Circulation,2013,77(10):2578-2585.
[11] Erkkilä AT, Matthan NR, Herrington DM,et al. Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD[J]. J Lipid Res,2006,47(12):2814-2819.
[12] Guallar E,Sanz-Gallardo M,van't Veer P,et al. Mercury,fish oils,and the risk of myocardial infarction[J]. N Engl J Med,2002,347:1747-1754.
[13] Hu FB, Bronner L, Willett WC, et al.Fish and omega-3 fatty acid intake and risk of coronary heart disease in women[J]. JAMA,2002,287(14):1815-1821.
[14] Gerber PA, Gouni-Berthold I, Berneis K. Omega-3 fatty acids:role in metabolism and cardiovascular disease[J]. Curr Pharm Des,2013,19(17):3074-3093.
[15] Tsuburaya R, Yasuda S, Ito Y,et al.Eicosapentaenoic acid reduces ischemic ventricular fibrillation via altering monophasic action potential in pigs[J].J Mol Cell Cardiol,2011,51(3):329-336.
[16] Kumar S,Sutherland F,Morton JB,et al.Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion[J]. Heart Rhythm,2012,9(4):483-491.
[17] Mayyas F,Sakurai S,Ram R,et al.Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model[J].Cardiovasc Res,20l1,89(4):852-861.
[18] Belevych AE, Ho HT,Terentyeva R,et al.Dietary omega-3 fatty acids promote arrhythmogenic remodeling of cellular Ca(2+)handling in a postinfarction model of sudden cardiac death[J].PLoS One,2013,8(10): e78414.
[19] Mariani J,Doval HC,Nul D,et al.N-3 polyunsaturated fatty acids to prevent atrial fibrillation:updated systematic review and meta-analysis of randomized controlled trials[J].J Am Heart Assoc,2013,2(1):e5-33.
[20] Macchia A, Grancelli H, Varini S,et al.Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation:results of the FORWARD(Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation)trial[J].J Am Coll Cardiol,2013,61(4):463-468.
[21] Zhao Z, Wen H, Fefelova N,et al.Docosahexaenoic acid reduces the incidence of early afterdepolarizations caused by oxidative stress in rabbit ventricular myocytes[J].Front Physiol,2012,3:252.
[22] Sasaki J,Yokoyama M,Matsuzaki M,et al.Relationship between coronary artery disease and non-HDL-C,and effect of highly puriflied EPA on the risk of coronary artery disease in hypercholesterolemic patients treated with statins:sub-analysis of the Japan EPA Lipid Intervention Study(JELLS)[J].J Atheroscler Thromb,2012,19(2):194-204.
[23] Gaio EG, Karla L,Aline CS,et al.Safety in the hypertriglyceridemia treatment with n-3 polyunsaturated fatty acids on glucose metabolism in subjects with type 2 diabetes mellitus[J]. Nutr Hosp,2015,31(2):570-576.
[24] 詹麒平,朱昱哲,张昕,等.高含量DHA/EPA甘油三酯的降血脂和保肝作用的研究[J].食品工业科技,2014,13:355-358.
[25] 张晾.不同比率n-6/n-3多不饱和脂肪酸对动脉粥样硬化发展的干预机制探讨[D].山东:山东师范大学,2009.
[26] 陈燕芬,李肖蓉,王如兴,等.ω-3多不饱和脂肪酸对脂代谢的影响及其抗炎抗心律失常作用的相关研究[D].南京:南京医科大学,2007.
[27] 朱昱哲,王静凤.高含量DHA/EPA甘油三酯调节脂质代谢和改善胰岛素抵抗作用的研究[D].山东:中国海洋大学,2013.
[28] Zheng JS,Huang T,Yang J, et al.Marine N-3 polyunsaturated fatty acids are inversely associated with risk of type 2 diabetes in Asians: a systematic review and meta-analysis[J]. PLoS One,2012,7(9):e44525.
[29] Huang T, Wahlqvist ML, Xu T,et al.Increased plasma n-3 polyunsaturated fatty acid is associated with improved insulin sensitivity in type 2 diabetes in China[J]. Mol Nutr Food Res, 2010,54(Suppl 1):S112-S119.
[30] 肖新才,刘健,罗晓林,等.代谢综合征患者血清磷脂脂肪酸构成及其与胰岛素抵抗的关系研究[J].中华疾病控制杂志,2012,16(5):388-391.
[31] 何天博,姜玲玲.DHA抑制2型糖尿病大鼠肝脏炎症改善胰岛素抵抗的机制研究[D].河北:河北医科大学,2013.
[32] 潘小姣,夏宁.n-3多不饱和脂肪酸对SD大鼠患2型糖尿病的防治作用以及对其凝血、纤溶系统的影响[D].广州:广州医科大学,2014.
[33] Sekikawa A, Doyle MF, Kuller LH. Recent findings of long-chain n-3 polyunsaturated fatty acids(LCn-3 PUFAs)on atherosclerosis and coronary heart disease(CHD)contrasting studies in Western countries to Japan[J]. Trends Cardiovasc Med,2015,25(8):717-723.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(3):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(3):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(3):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(3):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]张宝丽,许建忠,综述,等.副肾动脉与高血压的研究进展[J].心血管病学进展,2016,(3):224.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.002]
ZHANG Baoli,XU Jianzhong,TANG Xiaofeng,et al.Accessory Renal Artery and Hypertension[J].Advances in Cardiovascular Diseases,2016,(3):224.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.002]
[6]段兴连,综述,常静,等.阻塞性睡眠呼吸暂停低通气综合征及其干预治疗对心血管疾病的临床意义[J].心血管病学进展,2016,(3):289.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.019]
DUAN Xinglian,CHANG Jing.Clinical Significance of OSAHS and Its Intervention Therapy on
Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(3):289.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.019]
[7]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(3):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[8]何平,任洁.C反应蛋白与高血压的关联性研究进展[J].心血管病学进展,2015,(5):596.[doi:10.3969/j.issn.1004-3934.2015.05.018]
HE Ping,REN Jie.Research Progress of C-Reactive Protein and Hypertension[J].Advances in Cardiovascular Diseases,2015,(3):596.[doi:10.3969/j.issn.1004-3934.2015.05.018]
[9]梅宝菲,孔一慧,李为民.睡眠障碍与心血管疾病研究新进展[J].心血管病学进展,2015,(5):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
MEI Baofei,KONG Yihui,LI Weimin.Relationship Between Somnipathy and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2015,(3):603.[doi:10.3969/j.issn.1004-3934.2015.05.020]
[10]成哲,罗素新,夏勇.LCZ696在心血管疾病中的研究进展[J].心血管病学进展,2015,(5):606.[doi:10.3969/j.issn.1004-3934.2015.05.021]
CHENG Zhe,LUO Suxin,XIA Yong.Research Progress of LCZ696 in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2015,(3):606.[doi:10.3969/j.issn.1004-3934.2015.05.021]